Primary care strategies to improve childhood immunisation uptake in developed countries: systematic review. by Williams, Nia et al.
Williams, N; Woodward, H; Majeed, A; Saxena, S (2011) Primary
care strategies to improve childhood immunisation uptake in devel-
oped countries: systematic review. JRSM Short Rep, 2 (10). p. 81.
ISSN 2042-5333 DOI: 10.1258/shorts.2011.011112
Downloaded from: http://researchonline.lshtm.ac.uk/1126650/
DOI: 10.1258/shorts.2011.011112
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
Primary care strategies to improve
childhood immunisation uptake in
developed countries: systematic
review
Nia Williams • Helen Woodward • AzeemMajeed •
Sonia Saxena
Department of Primary Care and Public Health, Imperial College London, London W6 8RF, UK
Correspondence to: Nia Williams. Email: nia.williams00@ic.ac.uk
Summary
Objectives To conduct a systematic review of strategies to optimize
immunisation uptake within preschool children in developed countries.
Design Systematic review.
Setting Developed countries
Participants Preschool children who were due, or overdue, one or
more of their routine primary immunisations.
Main outcome measures Increase in the proportion of the target
population up to datewith standard recommended universal vaccinations.
Results Forty-six studies were included for analysis, published
between 1980 and 2009. Twenty-six studies were randomized controlled
trials, 11 were before and after trials, and ninewere controlled intervention
trials. Parental reminders showed a statistically significant increase in
immunisation rates in 34% of included intervention arms. These effects
were reported with both generic and specific reminders and with all
methods of reminders and recall. Strategies aimed at immunisation
providers were also shown to improve immunisation rates with a median
change in immunisation rates of 7% when reminders were used, 8% when
educational programmeswere used and 19%when feedback programmes
were used.
Conclusion General practitioners are uniquely positioned to influence
parental decisions on childhood immunisation. A variety of strategies
studied in primary care settings have been shown to improve
immunisation rates, including parental and healthcare provider
reminders.
Introduction
Childhood vaccines currently save 3million lives a
year globally and are among the most successful
and cost-effective public health interventions of
the 20th century.1 Immunisation has been respon-
sible for substantial falls in serious bacterial infec-
tious diseases in children including tetanus,
diphtheria, meningococcal serogroup C (MenC),
measles and Haemophilus Influenzae B (HiB),
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1
since their inclusion in the UK primary vacci-
nation schedule.2 Immunising children not only
protects individuals from infection but also con-
tributes to population-based immunity by redu-
cing the circulation of infectious agents leading
to community-wide health gains.3
To maximize the potential population-wide
benefits of routine vaccination through herd
immunity, the World Health Organization
(WHO) has set national targets of 95% coverage
annually for each antigen in the routine immunis-
ation schedule by 2 years of age.4 Yet recent figures
show that these targets are not being met in many
countries. In England, in the quarter between
January and March 2010, vaccination coverage
for the measles, mumps and rubella vaccine
(MMR), pneumococcal vaccine (PCV) booster
and the Hib/MenC vaccines were 88%, 88% and
90%, respectively, at 24 months of age.5
Coverage tends to be lowest in deprived, urban
areas with mobile populations.6–8 For example,
childhood immunisation rates for London are sub-
stantially below the national average with levels in
one East London borough (Bexley) of just 63%,
71% and 74% for the PCV (Pneumococcal conju-
gate vaccine) booster, MMR and Hib/MenC,
respectively.5 In areas of low MMR coverage, this
has resulted in outbreaks, with a high proportion
of those affected being under 1 year of age, who
were most likely infected by unimmunised older
contacts. One consequence of this is that measles
and mumps have once again become endemic in
the UK, with over 1100 cases of measles and over
7000 cases of mumps reported in the UK in 2009,
14 years after local transmission of measles was
halted.9
Barriers to immunisation can stem from par-
ental concerns about risks, inadequate knowledge
and provision by providers, and generalized
systemic barriers involving the organization of
the health system and access to services.10
Ninety-eight percent of infants born in the UK
are registered with a UK general practitioner
(GP)11 and their first contact with their GP is
often at the primary vaccination. Hence, GPs and
practice nurses are uniquely positioned to influ-
ence a parent’s decisions to have their child
immunised.
Our objective was to conduct a systematic lit-
erature review aimed at providing GPs with up-
to-date, evidence-based guidelines on how to
improve uptake rates of primary immunisations
for children registered under their care. Our
research question was ‘How can primary care
practitioners in developed countries improve pre-
school immunization uptake?’
Methods
Search strategy and data sources
We systematically searched electronic databases
including MEDLINE, EMBASE, PsycInfo,
Cochrane and OpenSIGL from inception to 1
June 2010 using MESH and Key Terms including
immunis*, vaccin*, innoc* and rates, uptake and
coverage (Appendix 1) to identify studies report-
ing interventions to improve preschool immunis-
ation uptake and to evaluate their effectiveness
in children in developed countries.
We hand-searched the reference lists from
retrieved studies and reviews to find additional
studies and contacted experts in the field. We
also identified relevant grey literature such as con-
ference papers, dissertations and government
guidelines.
Study selection
Two reviewers (NW and HW) independently
screened titles and abstracts of all citations for eli-
gibility and retrieved those that met the inclusion
criteria. If insufficient information was available in
the abstract to decide on eligibility the whole
article was retrieved for review. Discrepancies
were resolved by discussion and by involving a
third reviewer (SS) when necessary.
We included experimental studies reporting
original research including randomized controlled
trials, controlled clinical trials, before and after
studies and interrupted time-series studies, pub-
lished in English. Our target population was chil-
dren under the age of 5 years living in developed
countries. We included studies reporting our main
outcome measure; the increase in the proportion
of the target population who were up to date
with standard recommended universal vacci-
nations. Outcomes could be for either single vacci-
nations or combinations of vaccines due. We
excluded studies for which the full article was
not available, and studies that did not contain
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any original data such as review articles, commen-
taries and correspondence.
Data extraction and quality assessment
The two reviewers independently extracted data
from included studies on study setting, partici-
pant characteristics, clinical setting, interventions
and outcomes measured. Included studies were
graded for methodological quality using 26
points from the 27 point score devised by Downs
and Black (Appendix 2).12
Results
A total of 32,624 studies were retrieved from the
electronic searches of which 32,410 were excluded
after reviewing their titles and abstracts. The
remaining 214 papers were retrieved for full text
review. Recommendations from experts in the
field and reviews of reference lists identified a
further 14 studies. A total of 46 papers met the
inclusion criteria (Figure 1).
The commonest reasons for exclusion were
failure to report interventions or outcomes of
interest and poor study design.
The 46 included studies were published
between 1980 and 2009. Twenty-six were random-
ized controlled trials, 11 were before and after
trials and nine were controlled intervention
trials. The studies originated mainly from the
USA (36) and the remainder originated from the
UK and Ireland (7), Australia (1), New Zealand
(1) and Finland (1). The study participants
ranged in age from 6 weeks to 11 years of age
but the majority of studies focused on preschool
children. Studies were conducted in different set-
tings including paediatric outpatient clinics,
family practices, primary care clinics, community
health centres, managed care organizations and
health maintenance organizations in the USA;
and community clinics and general practices in
the UK, New Zealand and Australia.
Studied interventions aimed to remind and/or
recall parents of upcoming or overdue vacci-
nations; targeted providers to improve uptake
through feedback, audit or chart prompts; pro-
vided simple education to parents within a
general practice setting or consisted of multicom-
ponent interventions.
Client-based interventions
Client-based interventions target the parent and
child to increase the demand for immunisation
services. Educating parents and communities on
the benefits of vaccinating their children can
empower parents to practice preventative health-
care and thereby improving immunisation uptake.
Reminder and recall
Reminders aim to advise parents of upcoming
vaccinations that are due and remind parents of
those children that are overdue. They vary in
methodology from automated telephone calls
and generic postcards to personalized letters and
even home visits.
Twenty-two included papers reported on 41
intervention arms studying parental reminders
and recalls.13–34 Details of the included studies are
seen in Table 1. The average score for study
quality using Down and Black’s quality scoring fra-
mework was 24.8 out of a potential 31 (range 21–
29.5). Fourteen (34%) of the 41 intervention arms
showed a statistically significant (P < 0.05) increase
Figure 1
Quorom diagram
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in immunisation rates (Szilagyi et al.29 did not report
significance). Overall, these studies reported a
median point change of 11% (mean 10%, range
–11% to 24%). Studies comparing usual care with
postal reminders alone17,19,20,23–26,30,33,34 reported
an overall median point change of 10% (mean
8.6%, range –11% to 19%). Studies looking at tele-
phone reminders alone14,17,28,31 reported an overall
median point change of 9.5% (mean 12%; range
3–24%). Those studies looking at the effect of the
combination of postal and telephone reminders on
vaccination rates13,15–17,21,31 reported an overall
median point change of 10.5% (mean 10.8%, range
2.8–19%). One study18 compared a traditional
reminder card with a card designed with health
belief model inmind. Hawe reported a 12% increase
in immunisation rates when the health belief model
reminder card was used.
Parental reminders have been shown to have an
overall positive effect on immunisation uptake.
These effects have been reported with both
generic and specific reminders and with all
methods of reminders and recall.
Parental education
In the context of this review, we considered only
educational programmes that could feasibly be
delivered within the setting of primary care and
we excluded studies reporting national or regional
education programmes.
Two of the included papers reported on two
intervention arms studying the effect of simple par-
ental education programmes on immunisation
uptake (Table 2).35,36 One study assessed the
impact of a promotional teddy bear featuring the
address of an information website for MMR and
one studied the impact of an interactive graphic
card and verbal explanation on immunisation
uptake. The quality of these two studies averaged
at 23.8 points from a possible 31. Neither study
showed a significant effect on immunisation rates
and the limited number of studies precludes us
from reaching an evidenced-based conclusion on
the effect of these strategies on parental behaviour.
Patient-held records
Only one study37 assessing the impact of patient-
held records effect on immunisation rates fulfilled
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the inclusion criteria (Table 3); it scored 22 from a
possible 31 points on study quality. This study did
not demonstrate a significant difference between
usual care and a home-based record booklet.
Therefore, it is not possible to come to an
evidence-based conclusion on the effect of this
strategy on immunisation uptake.
Provider-based interventions
Provider-based interventions aim to improve vac-
cination rates by reducing opportunities missed
by the medical professional to immunise children.
These include provider reminder/recall, assess-
ment and feedback, provider education and a
combination of some or all of these strategies.
Provider reminder/recall
This strategy aims to investigate client’s immunis-
ation status either by manual searching of notes or
by automatic computer notifications. Providers
are then notified either with paper or computer-
based chart prompts that the vaccination is due
or overdue.
Five of the included papers38–42 reported on six
intervention arms studying provider reminder/
recall strategies (Table 4). The studies averaged a
quality score of 23.7 from a possible 31 (range
21–27). Overall, these studies reported a median
point change of 7% (mean 10%, range –2% to
33%). Both manual searching and electronic
reminders were shown to have a positive effect
on immunisation rates.
Provider education
Provider education strategies aim to enhance
the knowledge of the immunisation provider
through a variety of methods including peer
support and the use of educational resources.
Educational tools may be one-off sessions or part
of continuing medical education.
Four of the included papers43–46 reported on
four intervention arms studying the effect of edu-
cating the provider of vaccinations on immunis-
ation rates (Table 3). The average quality score
for included studies was 22.4 (range 20–28).
Overall, these studies reported a median point
change of 8% (mean 10%, range 1–25%). The
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educational interventions varied from 1-hour peer
education sessions to regular continuing medical
education within the practice. Two studies
looked at provider education alone and two
studies looked at education in combination with
other interventions such as patient reminders.
Feedback
This strategy retrospectively evaluates the per-
formance of providers in childhood immunis-
ations and feeds this information back to the
medical practitioner. Feedback can also be com-
bined with other strategies for example financial
incentives or provider education.
Four of the included papers (Taylor, Sinn,
Harper, Fairbrother) reported on six intervention
arms studying the effect of provider feedback
combined with other strategies on immunisation
rates (Table 3). The average quality score for
these papers was 24.1 (range 21–28). Overall,
these studies reported a median point change of
19% (mean 17%, range 12–19%).
Multicomponent interventions
Multicomponent interventions encompass strat-
egies that use a combination of techniques to
improve immunisation uptake. These strategies
include combining interventions aimed at both
the client and the provider.
Eight of the included studies reported on eight
intervention arms that combined a variety of inter-
ventions aimed at improving immunisation
uptake (Table 5).51–58 The average score for
study quality was 20.5 from a possible 31 (range
17.5–24). Overall, these studies reported a
median point change of 15% (mean 19%, range
–4% to 47%). Three (38%) of the eight intervention
arms reported a statistically significant difference
in immunisation rate. Four (50%) studies did not
report the significance level for their intervention
arms. It is not possible to distinguish which com-
ponent of the intervention has had the greatest
effect on immunisation rates.
Discussion
Numerous studies have reported interventions to
improve primary immunisation uptake in chil-
dren. Effective interventions include parental
reminders, which can increase uptake by 11% in
the intervention arms. These effects were reported
with both generic and specific reminders and with
all methods of reminders and recall. Strategies
aimed at immunisation providers were also
shown to improve immunisation rates with a
median change in immunisation rates of 7%
when reminders were studied, 8% when edu-
cational programmes were studied and 19%
when feedback programmes were studied.
Providers who were educated by peers and
who received feedback on their performance as
vaccine providers were shown to have improved
immunisation uptake within their practice. There
was limited evidence for patient-held records
and parental education alone as strategies for
improving immunisation uptake.
Multicomponent strategy studies included
interventions aimed at parents alone (e.g. remin-
der cards plus educational posters) as well as
those that combined parental and healthcare
Table 3
Study characteristics of patient-held record studies
Paper Study
period
Setting and
population
Design Quality Intervention Outcome
Lakhani
et al.37
1980 West Lambeth
Health Authority,
London, UK;
mothers from
obstetric wards at
St Thomas’
Hospital
Randomized
controlled
trial
22 1. Usual care
(control group)
vs.
2. Home-based
record booklet
No significant
difference in the
uptake of
immunisations
between groups
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provider strategies (e.g. parental reminders plus
provider education). Melinkovich showed when
studying community and school health centres
in Denver, USA that combining parental and pro-
vider strategies led to the greatest point increase in
immunisation coverage in the multicomponent
strategy group of studies.53 The most successful
strategies appear to be those that target both the
healthcare provider and those that are to be
immunised.
Our search methods yielded more studies than
any similar previous review. We combined studies
from a variety of clinical settings and a range
of socioeconomic populations in developed
countries, which makes the results generalisable
in this setting. Included studies were heteroge-
nous in setting, service delivery, intervention
delivery and quality which made meta-analysis
difficult. We did not include studies from develop-
ing countries as the barriers to immunisation are
different from those in developed countries and
include financial barriers that are generally not rel-
evant to parents and general practitioners in many
developed countries that offer universal access to
primary care services. Grey literature, conference
papers and government documents were also
included in the review as well as research pub-
lished in peer-reviewed journals to ensure the
broadest possible range of studies and to mini-
mize publication bias. We excluded studies pub-
lished in languages other than English, which is
the main weakness of this study.
We did not examine the effect of GP financial
incentives on immunisation uptake. There is a
large literature of ‘pay for performance’ in health-
care and this has been a subject of previous sys-
tematic reviews, the inclusion of which is
outside the scope of this paper.59,60
Various sociodemographic factors have been
shown to reduce the likelihood of a child being
up to date with recommended vaccinations
including being from a lone parent family61,62
from an ethnic minority63,64 and living in urban
areas.65 The high level of mobility seen in these
populations is thought to contribute to these
differences.66,67 Interventions to increase vacci-
nation rates have a greater effect on those who
are most at risk of being under-immunised.
Hence, it is important that vaccine coverage data
are collected in a way that highlights differences
in uptake rates between socioeconomic and
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ethnic groups. This would help in the implemen-
tation and evaluation of public health pro-
grammes to improve immunisation rates in the
groups in the most need of intervention.
Childhood immunisation can continue to
benefit the health of children. For example, the
UK has seen a successful campaign to add pneu-
mococcal vaccination to the primary schedule
with a catch-up campaign for older children.
This has resulted in a substantial reversal of pre-
viously increasing trends with falls in hospital
admissions for bacterial pneumonia (20%) and
empyema (22%) in the 2 years after implemen-
tation, linked with uptake rates of 80% and 98%
after the first and second years of the campaign,
respectively.68
Conclusions
Maintaining high vaccine uptake rates is an essen-
tial component of the success of any vaccination
programme and in improving the health status
of children. Health planners and professionals
must engage actively with parents and the
public and invest in process measures that
ensure children receive primary prevention. Our
review has highlighted a number of interventions
that can help improve childhood immunisation
rates in developed countries. These include
reminding parents and providers of upcoming
and overdue immunisations and educating and
providing feedback to the vaccination providers.
Some additional research is required to test the
cost-effectiveness of these interventions and their
impact in groups with poor immunisation rates
or high risks of complications from vaccine pre-
ventable diseases.
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Appendix 2
Checklist for measuring study quality:
Downs S and Black N. The feasibility of
creating a checklist for the assessment of
the methodological quality of both of
randomised and non-randomised studies
of health care interventions. J Epidemiol
Community Health 1998;52:377–384
Reporting
1. Is the hypothesis/aim/objective of the study
clearly described?
Yes= 1
No= 0
2. Are the main outcomes to be measured clearly
described in the Introduction or Methods
section?
If the main outcomes are first mentioned in the
Results section, the question should be
answered no.
Appendix 1
TERM LINKING TERM
Immunis OR
Vaccin OR
Inoculat OR
Tetanus OR
Diptheria OR
Polio OR
Measles OR
Mumps OR
Rubella OR
Pertussis OR
Whooping OR
Haemophilus OR
Pneumococcal OR
MMR
AND
Rates OR
Coverage OR
Uptake
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Yes= 1
No= 0
3. Are the characteristics of the patients included
in the study clearly described?
Inclusion and/or exclusion criteria should be
given.
Yes= 1
No= 0
4. Are the interventions of interest clearly
described?
Treatments and placebo (where relevant) that
are to be compared should be clearly defined.
Yes= 1
No= 0
5. Are the distributions of principal confounders
in each group of subjects to be compared
clearly described?
Yes= 2
Partially= 1
No= 0
6. Are the main findings of the study clearly
described?
Simple outcome data (including denominators
and numerators) should be reported for all
major analyses and conclusions. (This question
does not cover statistical tests which are con-
sidered below).
Yes= 1
No= 0
7. Does this study provide estimates of the random
variability in the data for the main outcomes?
In non normally distributed data the inter-
quartile range of results should be reported. In
normally distributed data the standard error,
standard deviation or confidence intervals
should be reported. If the distribution of the
data is not described, it must assume that the
estimates used were appropriate and the ques-
tion should be answered yes.
Yes= 1
No= 0
8. Have all important adverse events that may be a
consequence of the intervention been reported?
Not going to use this one.
Yes= 1
No= 0
9. Have the characteristics of patients lost to follow
up been described?
Yes= 1
No= 0
10. Have actual probability values been reported
(eg 0.035 rather than< 0.05) for the main out-
comes except where the probability value is
less than 0.001?
Yes= 1
No= 0
External validity
All the following criteria attempt to address the
representativeness of the findings of the study
and whether they may be generalised to the popu-
lation fromwhich the study subjects were derived.
11. Were the subjects asked to participate in the
study representative of the entire population
from which they were recruited?
The study must identify the source population
for patients and describe how the patients
were selected.
Yes = 1
No= 0
Unable to determine= 0
12. Were those subjects who were prepared to par-
ticipate representative of the entire population
from which they were recruited?
The proportion of those asked who agreed
should be stated. Validation that the sample
was representative would include demonstrat-
ing that the distribution of the main confound-
ing factors are the same in the study sample
and the source population.
Yes = 1
No= 0
Unable to determine= 0
13. Were the staff, places and facilities where the
patients were treated, representative of the
treatment the majority of patients receive?
Yes = 1
No= 0
Unable to determine= 0
Internal validity – bias
14. Was an attempt made to blind study subjects to
the intervention they have received?
Yes = 1
No= 0
Unable to determine= 0
15. Was an attempt made to blind those measuring
the main outcomes of the intervention?
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Yes = 1
No= 0
Unable to determine= 0
16. If any of the results of the study were based on
“data dredging”, was this made clear?
Any outcome that had not been planned at the
outset of the study should be clearly indicated.
If no retrospective unplanned subgroup ana-
lyses were reported, then answer yes.
Yes = 1
No= 0
Unable to determine= 0
17. In trial and cohort studies, do the analyses
adjust for different lengths of follow up of
patients?
Where follow-up was the same for all study
patients the answer should be yes.
Yes = 1
No= 0
Unable to determine= 0
18. Were the statistical tests used to assess the main
outcomes appropriately?
Yes = 1
No= 0
Unable to determine= 0
19. Was compliance with the intervention/s
reliable?
Where there was non compliance with the
allocate treatment or where there was con-
tamination of one group, the question
should be answered no. For studies where
the effect of any misclassification was likely
to bias any association to the null, the ques-
tion should be answered yes.
Yes = 1
No= 0
Unable to determine= 0
20. Were the main outcome measures used accu-
rate (valid and reliable)?
For studies where the outcome measures are
clearly described, the question should be
answered yes. For studies which refer to
other work or that demonstrates the outcome
measures are accurate, the question should be
answered as yes.
Yes = 1
No= 0
Unable to determine= 0
Internal validity – confounding
(selection bias)
21. Were the patients in different intervention
groups (trail and cohort studies) or were the
cases and controls (case control) recruited
from same population?
EG patients for all comparison groups should
be selected from the same hospital. The ques-
tion should be answered unable to determine
for cohort and case control studies where
there is no information concerning the source
of patients included in the study.
Yes = 1
No= 0
Unable to determine= 0
22. Were study subjects in different intervention
groups (trials and cohort studies) or were the
cases and controls (case-control studies)
recruited over the same period of time?
For a study which does not specify the time
period over which patients were recruited,
the question should be answered unable to
determine.
Yes = 1
No= 0
Unable to determine= 0
23. Were study subjects randomised to interven-
tion groups?
Studies which state that subjects were random-
ised should be answered yes except were
method of randomisation would not ensure
random allocation. For example alternate allo-
cation would score no because it is predictable.
Yes = 1
No= 0
Unable to determine= 0
24. Was the randomised intervention assignment
concealed from both patients and health care
staff until recruitment was complete and
irrevocable?
All non-randomised studies should be
answered no.
Yes = 1
No= 0
Unable to determine= 0
25. Was there adequate adjustment for confound-
ing in the analyses from which the main find-
ings were drawn?
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This question should be answered no for trials
if: the main conclusion of the study were based
on analyses of treatment rather than intention
to treat; the distribution of known confounders
in the different treatment groups was not
described, or the distribution of known con-
founders differed between the treatment
groups but was not taken into account in the
analyses. In non randomised studies if the
effect of the main confounders was not investi-
gated or confounding was demonstrated but
no adjustment was made in the final analyses
the questions should be answered no.
Yes = 1
No= 0
Unable to determine= 0
26. Were losses of patient to follow up taken into
account?
If the number of patient lost to follow up
are not reported, the question should be
answered as unable to determine. If the pro-
portion lost to follow up was too small to
affect the main findings, the question
should be answered yes.
Yes = 1
No= 0
Unable to determine= 0
Power
27. Did the study have sufficient power to detect a
clinically important effect where the prob-
ability value for a difference being due to
chance is less than 5%?
Sample sizes have been calculated to detect the
difference of x% and y%.
Size of smallest intervention group
A <n1 0
B N1-n2 1
C N3-n4 2
D N5-n6 3
E N7-n8 4
F N8+ 5
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